Local research ethics committees should review their approval of prevention trial

doi:10.1136/bmj.312.7037.1036a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Catherine Read

Science writer 33 Cockshutt Road, Beauchief, Sheffield S8 7DY

EDITOR,—R D Bulbrook's editorial discusses who should take tamoxifen and for how long.1 The British aTTom (adjuvant tamoxifen treatment offer more) trial aims to recruit up to 20000 women with primary breast cancer. Many of these women could receive at least seven years' treatment with tamoxifen—two years more than the National Cancer Institute considers routinely advisable for …